Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancer

Clin Biochem. 1994 Aug;27(4):259-64. doi: 10.1016/0009-9120(94)90027-2.

Abstract

We have developed a new immunochemical test for fecal lactoferrin (LF) utilizing an enzyme-linked immunosorbent assay (ELISA). The ELISA had a sensitivity of about 10 micrograms/L of lactoferrin and the measurable range was 10.0-1000.0 micrograms/L (1.0-100.0 micrograms LF/g feces). The stability of lactoferrin in feces was greater than that of myeloperoxidase and leucocyte elastase. The fecal concentration of lactoferrin (mean +/- SD) in 35 normal subjects was 0.75 +/- 0.83 microgram/g feces, whereas that in 24 patients with colon cancer was 74.4 +/- 88.3 micrograms/g feces. The fecal lactoferrin concentration of 38 patient with active ulcerative colitis was 307.4 +/- 233.9 micrograms/g feces, and that in 36 patients with active Crohn's disease was 191.7 +/- 231.1 micrograms/g feces. The ELISA for human fecal lactoferrin might be useful in the diagnosis of colon disease.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Colitis, Ulcerative / diagnosis
  • Colitis, Ulcerative / metabolism*
  • Colonic Neoplasms / diagnosis
  • Colonic Neoplasms / metabolism*
  • Colonic Polyps / diagnosis
  • Colonic Polyps / metabolism
  • Colonoscopy
  • Crohn Disease / diagnosis
  • Crohn Disease / metabolism*
  • Enzyme-Linked Immunosorbent Assay
  • Feces / chemistry*
  • Female
  • Humans
  • Lactoferrin / blood
  • Lactoferrin / metabolism*
  • Male
  • Middle Aged
  • Regression Analysis

Substances

  • Lactoferrin